期刊文献+

丘脑底核-脑深部刺激术治疗帕金森病相关疼痛的疗效分析 被引量:3

Clinical efficacy analysis on subthalamic nucleus deep brain stimulation for Parkinson's disease related pain
下载PDF
导出
摘要 目的探讨丘脑底核-脑深部刺激术(STN-DBS)治疗帕金森病(PD)相关疼痛的疗效,以及疼痛与焦虑抑郁的相关性。方法对淮安市第二人民医院及南京医科大学附属脑科医院2018年1月—2019年12月,行双侧STN-DBS治疗的存在疼痛症状的43例中晚期PD患者的临床资料进行回顾分析。所有患者术后1个月开机并随访6个月,采用视觉模拟评分(VAS)法评价患者疼痛程度,汉密尔顿焦虑量表(HAMA)和汉密尔顿抑郁量表(HAMD)评价焦虑抑郁症状。总结STN-DBS治疗PD相关疼痛的疗效,分析疼痛与焦虑抑郁的相关性。结果本组患者中,28例患者(65.1%)存在疼痛微毁损效应。开机后6个月时,41例患者(95.3%)的疼痛症状减轻,VAS评分为(1.19±1.47)分,显著低于术前的(3.51±1.84)分(P<0.05),平均改善为66.1%。患者术后HAMA、HAMD评分分别为(13.16±4.52)分和(15.35±4.19)分,显著低于术前的(17.21±5.47)分和(21.60±4.82)分(均P<0.05)。VAS评分与HAMA、HAMD评分均呈正相关(r=0.664,r=0.505,均P<0.001)。结论中晚期PD患者的疼痛症状与焦虑抑郁有显著关系;STN-DBS治疗可有效改善其疼痛症状,并且多数患者存在疼痛微毁损效应。 Objective To summarize and analyze the clinical efficacy of subthalamic nucleus deep brain stimulation(STN-DBS)in the treatment of Parkinson's disease(PD)related pain and to analyze the correlation between pain and anxiety/depression.Methods The clinical data of 43 patients with advanced PD who underwent STN-DBS treatment in the Second People's Hospital of Huaian City and Nanjing Brain Hospital from January 2018 to December 2019 were analyzed retrospectively.All patients started up 1 month after operation and followed up for 6 months.The visual analogue scale(VAS)was used to evaluate the degree of pain.Hamilton anxiety scale(HAMA)and Hamilton depression scale(HAMD)were used to evaluate anxiety and depression symptoms.The efficacy of STN-DBS in the treatment of PD related pain,and the correlation between pain and anxiety/depression were summarized.Results The electrode position was accurate in 43 patients with PD,there were 28(65.12%)had microlesion effect(MLE)of pain,41(95.35%)had pain relief at 6 months postoperatively,VAS score was(1.19±1.47),significantly lower than baseline of(3.51±1.84)(P<0.05),with an average improvement of 66.10%.The postoperative HAMA and HAMD scores were(13.16±4.52)and(15.35±4.19),which were significantly lower than those before operation(17.21±5.47)and(21.60±4.82)(P<0.05),the correlation coefficients of HAMA,HAMD and VAS scores were 0.664(P<0.001),0.505(P<0.001).Conclusion Pain in patients with advanced PD is significantly related to anxiety and depression,STN-DBS can effectively alleviate the symptoms of PD related pain,and most of them have MLE of pain.
作者 周永 陈锐 支中文 章文斌 赵连东 ZHOU Yong;CHEN Rui;ZHI Zhong-wen;ZHAO Lian-dong;ZHANG Wen-bin(Department of Neurology,Huai'an Hospital Affiliated to Xuzhou Medical University,Huaian 223000,China;不详)
出处 《临床神经外科杂志》 CAS 2020年第5期538-542,共5页 Journal of Clinical Neurosurgery
基金 “十三五”国家重点研发计划子课题(2016YFC0105901NNZ) 江苏省重点病种规范化诊疗项目(BE2016614)。
关键词 帕金森病 疼痛 焦虑 抑郁 丘脑底核 脑深部刺激术 临床疗效 Parkinson's disease pain anxiety depression subthalamic nucleus deep brain stimulation clinical effect
  • 相关文献

参考文献3

二级参考文献28

  • 1张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 2Zhang ZX, Roman GC, Hong Z,et al. Parkinson's disease inChina: prevalence in Beijing, Xian, and Shanghai[ J]. Lancet,2005,365(9459): 595-597.
  • 3Postuma RB, Berg D, Stem M, et al. MDS clinical diagnosticcriteria for Parkinson、disease[ J]. Mov Disord, 2015,30( 12):1591-1601. DOI: 10.1002/mds.26424.
  • 4Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motorsymptoms of Parkinson's disease : diagnosis and management[ J ].Lancet Neurol, 2006,5(3): 235-245.
  • 5Goetz CG,Tilley BC, Shaftman SR,et al. Movement DisorderSociety-sponsored revision of the Unified Parkinson; s DiseaseRating Scale ( MDS-UPDRS) . scale presentation and clinimetrictesting results [ J ]. Mov Disord, 2008 , 23 ( 15): 2129-2170.DOI: 10.1002/mds. 22340.
  • 6Shah M, Muhammed N, Findley LJ, et al. Olfactory tests in thediagnosis of essential tremor [ J ]. Parkinsonism Relat Disord,2008,14(7) : 563-568. DOI: 10. 1016/j. parkreldis. 2007. 12.006.
  • 7Wenning GK, Shephard B, Hawkes C, et al. Olfactory functionin atypical parkinsonian syndromes [ J ]. Acta NeurologicaScandinavica, 1995,91(4): 247-250.
  • 8Muller A, Mtingersdorf M, Reichmann H, et al. Olfactoryfunction in Parkinsonian syndromes[ J]. J Clin Neurosci, 2002 , 9(5): 521-524.
  • 9Goldstein DS,Holmes C,Bentho O,et al. Biomarkers to detectcentral dopamine deficiency and distinguish Parkinson diseasefrom multiple system atrophy [ J ]. Parkinsonism Relat Disord,2008,14(8): 600-607. DOI: 10. 1016/j. parkreldis. 2008. 01.010.
  • 10Katzenschlager R, Zijlmans J, Evans A, et al. Olfactory functiondistinguishes vascular parkinsonism from Parkinson's disease[ J].J Neurol Neurosurg Psychiatry, 2004, 75(12) : 1749-1752.

共引文献1225

同被引文献29

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部